Combination therapy with a GLP-1 RA plus basal insulin has been reported to be highly effective in reducing HbA1c and preventing weight gain associated with insulin therapy, without increasing the risk of hypoglycemia [67,68]. This evidence concerns the gene GCG and Hypoglycemia.